About VITRO BIOPHARMA, INC.
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders. The company aims to become a leader in developing differentiated product candidates efficiently for the immunology and inflammatory market.
Development of Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorderscGMP-compliant manufacturing with ISO 9001:2015 and ISO 13485:2016 certified quality management systemsProprietary cell culture processes and MSC-Gro media for enhanced cell growth and therapeutic benefitsIn-house manufacturing of cell-based therapies with a focus on scalability and standardization
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VITRO BIOPHARMA, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.